Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes ...Middle East

PR Newswire - News
Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%. Results from the...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes )

    Apple Storegoogle play

    Also on site :